These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 35124446)

  • 21. Preventive Effect of Citrus aurantium Peel Extract on High-Fat Diet-Induced Non-alcoholic Fatty Liver in Mice.
    Han HY; Lee SK; Choi BK; Lee DR; Lee HJ; Kim TW
    Biol Pharm Bull; 2019; 42(2):255-260. PubMed ID: 30713255
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.
    Yamada K; Mizukoshi E; Sunagozaka H; Arai K; Yamashita T; Takeshita Y; Misu H; Takamura T; Kitamura S; Zen Y; Nakanuma Y; Honda M; Kaneko S
    Liver Int; 2015 Feb; 35(2):582-90. PubMed ID: 25219574
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic administration of recombinant IL-6 upregulates lipogenic enzyme expression and aggravates high-fat-diet-induced steatosis in IL-6-deficient mice.
    Vida M; Gavito AL; Pavón FJ; Bautista D; Serrano A; Suarez J; Arrabal S; Decara J; Romero-Cuevas M; Rodríguez de Fonseca F; Baixeras E
    Dis Model Mech; 2015 Jul; 8(7):721-31. PubMed ID: 26035386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of high-fat diet on the formation of depressive-like behavior in mice.
    Yu H; Qin X; Yu Z; Chen Y; Tang L; Shan W
    Food Funct; 2021 Jul; 12(14):6416-6431. PubMed ID: 34076000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Odd chain fatty acid metabolism in mice after a high fat diet.
    Ampong I; John Ikwuobe O; Brown JEP; Bailey CJ; Gao D; Gutierrez-Merino J; Griffiths HR
    Int J Biochem Cell Biol; 2022 Feb; 143():106135. PubMed ID: 34896612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted metabolomics study of fatty-acid metabolism in lean metabolic-associated fatty liver disease patients.
    Sun PQ; Dong WM; Yuan YF; Cao Q; Chen XY; Guo LL; Jiang YY
    World J Gastroenterol; 2024 Jul; 30(27):3290-3303. PubMed ID: 39086751
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P2Y2R Deficiency Ameliorates Hepatic Steatosis by Reducing Lipogenesis and Enhancing Fatty Acid β-Oxidation through AMPK and PGC-1α Induction in High-Fat Diet-Fed Mice.
    Dusabimana T; Park EJ; Je J; Jeong K; Yun SP; Kim HJ; Kim H; Park SW
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD mice.
    Chao J; Huo TI; Cheng HY; Tsai JC; Liao JW; Lee MS; Qin XM; Hsieh MT; Pao LH; Peng WH
    PLoS One; 2014; 9(2):e96969. PubMed ID: 24918580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventive effect of trans-chalcone on non-alcoholic steatohepatitis: Improvement of hepatic lipid metabolism.
    Karimi-Sales E; Ebrahimi-Kalan A; Alipour MR
    Biomed Pharmacother; 2019 Jan; 109():1306-1312. PubMed ID: 30551380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The protective mechanism of Lactobacillus plantarum FZU3013 against non-alcoholic fatty liver associated with hyperlipidemia in mice fed a high-fat diet.
    Chen M; Guo WL; Li QY; Xu JX; Cao YJ; Liu B; Yu XD; Rao PF; Ni L; Lv XC
    Food Funct; 2020 Apr; 11(4):3316-3331. PubMed ID: 32226996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A complementary method with PFBBr-derivatization based on a GC-EI-MS platform for the simultaneous quantitation of short-, medium- and long-chain fatty acids in murine plasma and feces samples.
    Zhou HX; Jiang Q; He X; Fu X; Liu JY
    Anal Methods; 2024 Apr; 16(15):2330-2339. PubMed ID: 38562090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic effect and autophagy regulation of myriocin in nonalcoholic steatohepatitis.
    Yang RX; Pan Q; Liu XL; Zhou D; Xin FZ; Zhao ZH; Zhang RN; Zeng J; Qiao L; Hu CX; Xu GW; Fan JG
    Lipids Health Dis; 2019 Oct; 18(1):179. PubMed ID: 31639005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulating Unsaturated Fatty Acids Delineate the Metabolic Status of Obese Individuals.
    Ni Y; Zhao L; Yu H; Ma X; Bao Y; Rajani C; Loo LW; Shvetsov YB; Yu H; Chen T; Zhang Y; Wang C; Hu C; Su M; Xie G; Zhao A; Jia W; Jia W
    EBioMedicine; 2015 Oct; 2(10):1513-22. PubMed ID: 26629547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolomic-proteomic combination analysis reveals the targets and molecular pathways associated with hydrogen sulfide alleviating NAFLD.
    Liu Z; Liu M; Fan M; Pan S; Li S; Chen M; Wang H
    Life Sci; 2021 Jan; 264():118629. PubMed ID: 33131747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Free fatty acids, not triglycerides, are associated with non-alcoholic liver injury progression in high fat diet induced obese rats.
    Liu J; Han L; Zhu L; Yu Y
    Lipids Health Dis; 2016 Feb; 15():27. PubMed ID: 26868515
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted metabolomics analysis reveals the association between maternal folic acid supplementation and fatty acids and amino acids profiles in rat pups.
    Liu Z; Liu R; Chou J; Yu J; Liu X; Sun C; Li Y; Liu L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jul; 1090():101-109. PubMed ID: 29803868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic Lipidomics and Molecular Imaging in a Murine Non-Alcoholic Fatty Liver Disease Model: Insights into Molecular Mechanisms.
    Rodríguez-Calvo R; Samino S; Girona J; Martínez-Micaelo N; Ràfols P; García-Altares M; Guaita-Esteruelas S; Junza A; Heras M; Yanes O; Correig X; Masana L
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32899418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Intervention of Catalpol on High-fat Diet Induced Nonalcoholic Fatty Liver Disease in Mice].
    Tian X; Xiong Q; Chen L; Wen JR; Ru Q
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Dec; 41(6):746-755. PubMed ID: 31907123
    [No Abstract]   [Full Text] [Related]  

  • 39. SGL 121 Attenuates Nonalcoholic Fatty Liver Disease through Adjusting Lipid Metabolism Through AMPK Signaling Pathway.
    Kim DE; Chang BY; Jeon BM; Baek JI; Kim SC; Kim SY
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32630596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deletion of ELOVL6 blocks the synthesis of oleic acid but does not prevent the development of fatty liver or insulin resistance.
    Moon YA; Ochoa CR; Mitsche MA; Hammer RE; Horton JD
    J Lipid Res; 2014 Dec; 55(12):2597-605. PubMed ID: 25281760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.